[Thyrostatic therapy in patients with liver cirrhosis].
The thyreostatic therapy of a hyperthyroidism in coincident chronic hepatopathy is problematic. On the one hand, this therapy may be an additional load, particularly by the development of a cholestasis for the ill liver. On the other hand, due to the hyperthyroidism disturbance of the liver function and liver diseases up to cholestatic hepatitis may develop. At the instance of two patients with liver cirrhosis, whose simultaneous hyperthyroidism was treated thyreostatically, the therapeutic problems are represented. On the basis of the treatment of a not small number of patients with this constellation of findings we recommend the use of Thiamazol as therapy of choice in the at present, usual lower initial dosage. If functional disturbances of the liver and other side effects appear under this therapy, the radio-iodine therapy offers itself as alternative.
C
C
Rink
M
M
Klaua
E
E
Mertens
G
G
Schneider
R
R
Nilius
D000328:Adult; D013956:Antithyroid Agents / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D006980:Hyperthyroidism / Q000150:complications* / Q000188:drug therapy; D008103:Liver Cirrhosis / Q000150:complications*; D008297:Male; D008713:Methimazole / Q000627:therapeutic use; D008875:Middle Aged
D013956:Antithyroid Agents; D008713:Methimazole
Thyreostatische Therapie bei Patienten mit Leberzirrhose.